Compare MGNI & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGNI | AXGN |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | 514 | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.6B |
| IPO Year | 2014 | 2013 |
| Metric | MGNI | AXGN |
|---|---|---|
| Price | $24.01 | $43.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 9 |
| Target Price | $25.22 | ★ $42.33 |
| AVG Volume (30 Days) | ★ 2.2M | 1.2M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 493.75 | N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | $156,414,000.00 | ★ $225,208,000.00 |
| Revenue This Year | $6.28 | $20.57 |
| Revenue Next Year | $9.76 | $16.68 |
| P/E Ratio | $150.44 | ★ N/A |
| Revenue Growth | ★ 25.45 | 20.21 |
| 52 Week Low | $10.82 | $15.27 |
| 52 Week High | $26.84 | $52.91 |
| Indicator | MGNI | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 51.23 | 43.29 |
| Support Level | $22.44 | $38.75 |
| Resistance Level | $25.53 | $44.83 |
| Average True Range (ATR) | 0.88 | 2.14 |
| MACD | -0.12 | -0.31 |
| Stochastic Oscillator | 25.07 | 48.44 |
Magnite is a supply-side advertising platform that provides technology and yield management solutions to content publishers, enabling them to monetize their digital advertising inventory. Magnite receives a percentage of all advertising inventory that it sells. 43% of Magnite's revenue is derived from connected television, or CTV, streaming platforms, 40% from mobile applications, and the remainder from general websites. Beyond the typical monetization responsibilities inherent to an SSP, Magnite also provides upstream advertising servers to CTV publishers, allowing them to have granular control over direct-sold, programmatic guaranteed, and open-auction logic. Magnite competes with other independent SSPs, supply path optimization solutions, and closed ecosystems like Meta.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.